Look into AbbVie's strategy a company built around its blockbuster Humira, now diversifying its pipeline after the patent ...

The companies Kymera Therapeutics, Immunovant, and Dyne Therapeutics bagged the biggest biotech funding rounds overall in ...

Find out about TECregen's, a Basel-based company developing novel biologics designed to rejuvenate the thymus, “thymopoietics ...

As we head into the 2026, let's take a look at biotech licensing deals and M&As that were inked in December 2025.

Leyden Labs is taking a different approach to preventing respiratory infections by focusing on the nose as the point of intervention. Instead of trying to generate systemic immunity, the Dutch biotech ...

Podcasts are a great way to learn and engage listeners with stories that may strike their interest, particularly in the world of biotech. Whether you’re commuting to work, cleaning the house, going ...

Last year, we took a look at the biotech trends that we thought would shape 2024. Now, as we enter the new year, the biotech industry is continuing to evolve at a rapid pace, and 2025 is shaping up to ...

Asking whether China is the future of the biotech industry might seem counterintuitive, considering the current biotech geopolitical context. If you haven’t followed this series of events, a ...

AI has completely shifted the paradigm in the biotech industry. The past year has seen a gold rush in AI applications for the biopharma sector, for drug and protein discovery, or even treatment ...